{"organizations": [], "uuid": "1ac107117d915b51f0facd45bc1a8eece160d138", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/03/06/globe-newswire-tricore-announces-dr-michael-crossey-as-chief-executive-officer-president.html", "country": "US", "domain_rank": 767, "title": "TriCore Announces Dr. Michael Crossey as Chief Executive Officer & President", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-07T02:00:00.000+02:00", "replies_count": 0, "uuid": "1ac107117d915b51f0facd45bc1a8eece160d138"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/03/06/globe-newswire-tricore-announces-dr-michael-crossey-as-chief-executive-officer-president.html", "ord_in_thread": 0, "title": "TriCore Announces Dr. Michael Crossey as Chief Executive Officer & President", "locations": [], "entities": {"persons": [{"name": "nick dayan", "sentiment": "negative"}, {"name": "michael crossey", "sentiment": "negative"}, {"name": "robin divine", "sentiment": "none"}, {"name": "crossey", "sentiment": "none"}], "locations": [{"name": "albuquerque", "sentiment": "none"}, {"name": "new mexico", "sentiment": "none"}], "organizations": [{"name": "tricore", "sentiment": "none"}, {"name": "tricore reference laboratories", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Albuquerque, NM,March 06, 2018(GLOBE NEWSWIRE) --\nTriCore Contact:\nDr. Nick Dayan\nChief Administrative Officer\n(505) 938-8991\nNicholas.Dayan@tricore.org\nTriCore Announces Dr. Michael Crossey as Chief Executive Officer & President\nFor Immediate Release (Albuquerque, New Mexico ) - March 6, 2018 – TriCore Reference Laboratories is pleased to announce that the board of directors has appointed Michael Crossey, MD, PhD, to the position of CEO and president, effective immediately.\nDr. Crossey’s appointment is a clear reflection of the company’s current state: Ready to take on the future! Robin Divine, chair of TriCore’s board of directors, stated: “Enormous opportunity for TriCore lies ahead. We couldn’t be happier with Dr. Crossey accepting this position and moving us down the path of continued success.”\nFor the past 20 years since TriCore’s inception, Dr. Crossey has served the organization in various capacities, from pathologist to chief medical officer to interim chief executive officer. He brings decades of experience and internationally recognized expertise in clinical laboratory medicine to the company.\nSays Dr. Crossey of his new position: “I'm honored, and I'm grateful to the board for the opportunity to lead this exceptional organization of creative, dedicated and talented professionals.\"\n###\nTriCore Reference Laboratories is an independent, not-for-profit, clinical reference laboratory founded and headquartered in Albuquerque, New Mexico, co-sponsored by Presbyterian Healthcare Services and University of New Mexico Health Sciences Center. TriCore provides over 2,900, full-service, state-of-the-art laboratory tests to healthcare professionals and their patients. TriCore also provides analytics and research services, supporting healthcare and scientific organizations worldwide.\nFor more information, visit tricore.org .\nAttachment:\nA photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/68207f80-51fb-4664-84de-80bee403f3fc\nNick Dayan TriCore Reference Laboratories 5059388991 nicholas.dayan@tricore.org\nSource:TriCore Reference Laboratories", "external_links": ["http://www.globenewswire.com/NewsRoom/AttachmentNg/68207f80-51fb-4664-84de-80bee403f3fc", "https://www.globenewswire.com/Tracker?data=qR9_ch50STL-nc1veoEggJPHs62uadFJYMAqlYa-dyTI-TOFQqwJNODGPPrmRvGX74i6BvG1rrTjI_jo5Un6BhKqfCY6BxpAv3dBPzKy8Lv9dIUrzlEm3v8XdJtOXW4z", "https://www.globenewswire.com/Tracker?data=2B-4nWtx7zGL9kiK6JPff8WVnfvK7lxL5QfjwEhZi8I75ROHJxAzDf680JfSPxiDbslr-_2CSJC5kkHCDEoTzA==", "https://www.globenewswire.com/Tracker?data=dNXPjPL_7WZAD1-HS0D_4if6x7l8d7pqvZ6TorhPk3zQciOimiP5dxafUrkLmNeDRZiRfsPj-b1g-X2kLk3Z2wd2rIBDYuo1npGs-WTdj_erFr3qQAk-pySoaQl02EK7xf-xJUhGiVkVTpqpa-Sun_6Jd6m4D4EGG1K1gv2pMTQPxBkIZFatHHQTxdRGIfFmOHk9h0RG0Rt7e7JjgjFvWgeZOlX-6nl-jUtsda2VgxZObxcTxIBqsk70FZl1NlKbMTTQFf2I4aVYkTJ4YCabJQ==", "https://www.globenewswire.com/NewsRoom/AttachmentNg/68207f80-51fb-4664-84de-80bee403f3fc/en"], "published": "2018-03-07T02:00:00.000+02:00", "crawled": "2018-03-07T02:19:47.009+02:00", "highlightTitle": ""}